Healthcare Trust HTA announces its next round of earnings Monday. Here's Benzinga's advanced look at Healthcare Trust's Q2 earnings report.
Earnings and Revenue
Based on management's projections, Healthcare Trust analysts model for earnings of 7 cents per share on sales of $176.69 million.
The analyst consensus estimate would represent a 82.05 percent decline in the company's EPS figure. Sales would be up 26.64 percent from the year-ago period. Here's how the company's EPS has stacked up against analyst estimates in the past:
| Quarter | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
| EPS Estimate | 0.07 | 0.09 | -0.01 | |
| EPS Actual | 0.41 | 0.42 | 0.42 | 0.39 |
Stock Performance
Over the last 52-week period, shares are down 12.02 percent. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. Analyst estimates are adjusted lower for EPS and revenues over the past 90 days. Analysts have been rating Healthcare Trust stock as Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Don't be surprised to see the stock move on comments made during its conference call. Healthcare Trust's Q2 conference call is scheduled to begin at 8:00 a.m. ET and can be accessed here: https://htareit.com/presentations/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
